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Introduction: The aim of this study was to evaluate and compare the clinical efficacy of 
propofol-based deep sedation (PBDS) for endoscopic retrograde cholangiopancreatography 
(ERCP) procedure in sick (American Society of Anesthesiologists [ASA] physical status III–IV) 
and nonsick (ASA physical status I–II) elderly patients in a teaching hospital in Thailand.
Methods: We undertook a retrospective review of the anesthesia or sedation service records 
of elderly patients who underwent ERCP procedures from October 2007 to September 2008. 
All patients were classified into two groups according to the ASA physical status. In group A, 
the patients had ASA physical status I–II, while in group B, the patients had ASA physical 
status III–IV . The primary outcome variable of the study was the successful completion of the 
procedure. The secondary outcome variables were sedation-related adverse events during and 
immediately after the procedure.
Results: There were 158 elderly patients who underwent ERCP procedure by using PBDS dur-
ing the study period. Of these, 109 patients were in group A and 49 patients were in group B. 
There were no significant differences in age, gender, weight, duration of ERCP, indication of 
procedure, and the mean dose of fentanyl, propofol, and midazolam between the two groups. 
All patients in both groups successfully completed the procedure except eight patients in group 
A and three patients in group B (P = 0.781). Overall, respiratory and cardiovascular adverse 
events in both groups were not significantly different. All adverse events were easily treated, 
with no adverse sequelae.
Conclusion: In the setting of a developing country, PBDS for ERCP procedure in sick elderly 
patients by trained anesthetic personnel with appropriate monitoring was safe and effective. 
The clinical efficacy of this technique in sick elderly patients was not different or worse than 
in nonsick elderly patients. Serious adverse events were rare in our population.
Keywords: deep sedation, endoscopic retrograde cholangiopancreatography, propofol (ERCP), 
sick, elderly, American Society of Anesthesiologists (ASA), developing country
Introduction
Despite an increase in the number of patients with hepatobiliary tract diseases, surgical 
treatment is limited along with risky outcomes such as bleeding, infection or improper 
postoperative pain control. Endoscopic retrograde cholangiopancreatography (ERCP) 
is an effective treatment with fewer complications, lower cost, and shorter recovery 
time than surgery especially for biliary tract abnormalities.1 Many patients requiring 
ERCP are older, sicker, and have significant comorbidity. ERCP is an invasive proce-
dure requiring both endoscopy and anesthesia/sedation. Anesthesia consultation before 
the procedure is needed. Fluid and electrolyte disorders should be corrected and any 
infection treated. Antibiotic prophylaxis is recommended due to the infection risks. Therapeutics and Clinical Risk Management 2011:7 submit your manuscript | www.dovepress.com
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In practice, most ERCP procedures are performed in the 
endoscopy room, with special precautions. The type of 
anesthesia used is decided according to the patient’s medical 
condition, the anesthesiologist’s preference, and the type of 
endoscopic intervention. Local anesthesia with mild sedation 
can be used, but to assure better patient comfort during this 
complicated procedure, short-term general anesthesia or deep 
sedation is preferred. In our hospital, the majority of ERCP 
procedures were performed under deep sedation.2,3
We conducted a retrospective study to evaluate and to 
compare the clinical efficacy of the propofol-based deep 
sedation (PBDS) technique for ERCP procedure in nonsick 
(American Society of Anesthesiologists [ASA] physical 
  status I, II) and sick (ASA physical status III, IV) elderly 
patients in a tertiary-care teaching hospital in Thailand. 
The aim of our study was to confirm that in the setting of 
a developing country, PBDS for ERCP procedure in sick 
elderly patients by trained anesthetic personnel was safe 
and effective and was not different or worse than in nonsick 
elderly patients.
Methods
Patients
The elderly patients who underwent ERCP procedure at Siriraj 
GI Endoscopy Center, Faculty of Medicine, Siriraj Hospital, 
between October 2007 and September 2008 were enrolled in 
the present study. Inclusion criteria were the elderly patients 
(age $60 years) who underwent ERCP procedure by using 
PBDS technique. ERCP procedures performed in operating 
rooms (ORs) and the procedures performed without sedation, 
or procedures performed under monitored anesthesia care 
and general anesthesia were excluded.
Study design
This study was a retrospective descriptive study. All elderly 
patients were classified into two groups according to their 
ASA physical status. In group A, the patients had ASA physi-
cal status I–II. In group B, the patients had ASA physical 
status III–IV . The primary outcome variable of the study was 
the successful completion of the procedure. A failed proce-
dure was defined as a procedure that could not be completed 
by using the PBDS technique when under deep sedation or 
when sedation-related serious adverse events, such as severe 
hypoxemia (oxygen saturation [SpO2] ,85% for longer than 
3 minutes, which cannot be relieved by airway management) 
or severe cardiorespiratory instability occur. The secondary 
outcome variables were sedation-related adverse events 
  during and immediately after the procedure.
endoscopy procedure
All ERCP procedures were carried out using an Olympus® 
Video Duodenoscope (TJF 160 R; Olympus   Corporation, 
Tokyo, Japan). The success rate in both groups was recorded. 
The successful completion of the procedure was defined as 
completion of the procedure as intended without additional 
general anesthesia once the procedure had started. After com-
pletion of the procedure, admission into the inpatient hospital 
service was arranged to rule out post-ERCP complications.
Sedation-related procedure
The patients were monitored with noninvasive blood pres-
sure, electrocardiogram (ECG) and pulse oximetry. End-tidal 
carbon dioxide (ETCO2) monitoring with capnography was 
not used during sedation. All patients received oxygen supple-
mentation via an oxygen canula (3 L/minute). All procedures 
were done by using the PBDS technique and all patients were 
deeply sedated, according to guidelines of the ASA.4 When, 
the procedure was a failure, general anesthesia with endotra-
cheal tube was carried out. Sedative/analgesic agents used 
in both groups were propofol, fentanyl, and midazolam. The 
dose of sedative and analgesic agents was assessed.
Sedation-related adverse events
All sedation-related adverse events were recorded. Sedation-
related adverse events were defined as follows: hypertension 
or hypotension (increase or decrease in blood pressure by 
20% from baseline); tachycardia or bradycardia (increase 
or decrease in heart rate by 20% from baseline); any cardiac 
arrhythmias; hypoxia (oxygen desaturation, SpO2 , 90%); 
airway obstruction.
Statistical analysis
Results were expressed as mean ± standard deviation (SD) 
or percentage (%), when appropriate. Comparisons between 
group A and B were compared by using χ2 tests (for categori-
cal variables), χ2 square tests for trend (for ordinal variables), 
and two-sample independent t-test (for continuous variables). 
The statistical software package SPSS for Windows (v 11; 
SPSS, Inc, Chicago, IL) was used to analyze the data. All 
statistical comparisons were made at the two-sided 5% level 
of significance.
Results
Four hundred and eighty-two patients who underwent ERCP 
procedures during the study period were enrolled in the study. 
After matching age, gender, indication of procedure, as well 
as type of anesthetic technique and type of sedative agent, Therapeutics and Clinical Risk Management 2011:7 submit your manuscript | www.dovepress.com
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there were 158 elderly patients who underwent ERCP by 
using PBDS. Of these, 109 patients had ASA physical status 
I–II (Group A) and 49 patients had ASA physical status III–IV 
(Group B). There were no statistically significant differences 
in age, gender, weight, and procedure time and indications 
between the two groups (Table 1).
All PBDS was given by the anesthetic personnel directly 
supervised by a staff anesthesiologist physically present in the 
endoscopy room. All sedated patients were deeply sedated, 
according to guideline of the ASA.4 Anesthetic personnel 
included residents in the anesthesiology residency program and 
anesthetic nurses who are well trained in general anesthesia, 
intravenous sedation, airway management including intubation, 
and cardiopulmonary resuscitation. Cardiovascular monitoring, 
including blood pressure measurements, ECG, heart and 
respiratory rate, and SpO2, was performed. ETCO2 monitoring 
was not used during deep sedation. No premedications were 
used before the procedure. All patients in both groups were 
oxygenated with 100% O2 via a nasal canula.
Table 2 shows the success rate and sedative/analgesic 
agents used in the sick and nonsick groups. All patients in 
both groups were concluded with successful completion of 
the procedure except for eight patients in group A and three 
patients in group B (P = 0.781). All failed procedures were 
successfully completed by using general anesthesia with 
endotracheal tube. The combination of fentanyl, propofol, 
and midazolam was used and there was no statistically 
significant difference in the mean doses of fentanyl, propofol, 
and midazolam between the two groups.
Table 1 Characteristics of patients, duration of procedure, and 
indications of procedure
Group A  
(n = 109)
Group B  
(n = 49)
P-value
Age (year) (mean, SD) 63.3 (15.0) 75.1 (9.6) 0.211
Gender (n, %): Male 52 (47.7) 25 (52.0) 0.700
              Female 57 (52.3) 24 (49.0)
Weight (kg) (mean, SD) 56.1 (11.3) 55.4 (10.8) 0.427
ASA physical status (n, %) ,0001*
  I–II 109 (100.0) 0
  III–IV 0 49 (100.0)
Duration of procedure  
(minutes) (mean, SD)
35.7 (19.3) 38.5 (25.3) 0.063
Indications (n, %) 0.665
  Cholelithiasis 59 (54.1) 23 (47.0)
  hepatobiliary tract tumor 31 (28.5) 17 (34.7)
  Biliary tract stricture 11 (10.1) 5 (10.2)
  Others 8 (7.3) 3 (6.1)
Notes: Group A: ASA physical status I–II; Group B: ASA physical status III–IV. 
*Considered to be statistically significant.
Abbreviations: ASA, American Society of Anesthesiologists; SD, standard deviation.
Table 2 Success rate and sedative/analgesic agents used in both 
groups
Group A  
(n = 109)
Group B  
(n = 49)
P-value
Success rate (n, %) 101 (92.7) 46 (93.9) 0.781
Sedative/analgesic agents (mean, SD)
Fentanyl
  mg/kg 0.001 (0.000) 0.001 (0.000) 0.717
  mg/kg/h 0.002 (0.001) 0.002 (0.001) 0.139
Propofol
  mg/kg 3.87 (2.47) 3.20 (1.94) 0.210
  mg/kg/h 7.00 (3.84) 5.89 (3.40) 0.100
Midazolam
  mg/kg 0.03 (0.01) 0.02 (0.01) 0.297
  mg/kg/h 0.06 (0.05) 0.05 (0.04) 0.167
Notes: Group A: ASA physical status I–II; Group B: ASA physical status III–IV.
Abbreviation: SD, standard deviation.
Table 3 Sedation-related adverse events (n, %)
Group A  
(n = 109)
Group B  
(n = 49)
P-value
Overall 29 (26.6) 14 (28.6) 0.797
Respiratory 6 (5.5) 2 (4.1) 0.706
hypoxia  
(SpO2 , 90%)
 
2 (1.8)
 
1 (2.0)
 
0.930
Upper airway  
obstruction
4 (3.7) 1 (2.0) 0.589
Cardiovascular 23 (21.1) 12 (24.5) 0.635
hypotension 20 (18.3) 12 (24.5) 0.374
Bradycardia 3 (2.8) 0 0.241
Notes: Group A: ASA physical status I–II; Group B: ASA physical status III–IV.
Abbreviation: SpO2, oxygen saturation.
Table 3 lists sedation-related adverse events. Over-
all, 29 patients (26.6%) in group A and 14 patients 
(28.6%) in group B experienced adverse events. There 
were no significant differences in overall, respiratory and 
cardiovascular-related adverse events between the two groups. 
There were no procedure-related complications in either   
group.
Discussion
ERCP is an essential procedure among pancreatobiliary tract 
abnormality treatments, even in our institution where we have 
observed an increase in the number of these procedures every 
year. Therefore, it is mandatory to standardize a safe, easy, 
well-tolerated anesthesiological procedure which is feasible 
in the gastrointestinal (GI) endoscopy unit. In our experience, 
we have noted that topical anesthesia alone is not sufficient 
for pain-free procedures. In contrast, general anesthesia, 
which may be of benefit for the patient and endoscopist 
comfort, may be difficult to administer, especially in comor-
bid patients. Additionally, the lack of experience in anesthesia Therapeutics and Clinical Risk Management 2011:7 submit your manuscript | www.dovepress.com
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care among endoscopy personnel might increase the risk of 
complications.
In our hospital, we normally use deep sedation because of 
the above given reasons in conjunction with the preference of 
anesthesiologists.2 Our GI Endoscopy Center has few ETCO2 
monitors, and therefore ETCO2 monitoring is not routinely 
used during deep sedation for GI endoscopy procedures. 
Consequently, there are no special anesthetic techniques 
needed for this kind of anesthesia. Cardiopulmonary and 
other diseases that are more frequent in older and sicker 
patients have been regarded as the major risk factors for 
complications associated with endoscopy or sedation.5–7 Old 
age and high ASA physical status as important risk factors for 
endoscopy did not represent indications for providing general 
anesthesia more frequently for ERCP at our institution. 
However, the anesthetic technique depends on the experience 
of the anesthesiologists themselves.
Propofol, combined with short-acting benzodiazepine, 
with or without fentanyl, has already been used in several 
GI endoscopic procedures. In this study, we have shown 
that PBDS with low-dose midazolam and fentanyl, and 
low-dose propofol, is safe and well tolerated by the patient. 
Furthermore, it is well accepted by endoscopists. No patients 
enrolled in the study needed to be resuscitated during ERCP 
procedure. All patients could be discharged to the ward within 
60 minutes from the end of this procedure, and this discharge 
time was not correlated with age, ASA physical status, or 
total sedative doses.8
Patients were breathing spontaneously; however, SpO2 
was always over 95%, and age, ASA physical status, and the 
combination of sedative agents did not negatively influence 
this parameter. Also, heart rate was only partially affected. 
Sedation is performed to ensure the patient’s safety, to 
minimize physical discomfort or pain, to provide analgesia 
and procedural amnesia, to control behavior during the 
procedure and to return the patient to their pretreatment level 
of consciousness. Propofol is widely employed for anesthesia 
outside the OR because it is easy to use, has a good safety 
and efficacy profile due to its quick onset of action, rapid 
metabolism, significantly shorter recovery time, and has some 
anti-emetic effects.9–11 All of these properties are useful in 
endoscopic procedures.
Propofol is known to decrease blood pressure in young 
and old individuals.10 This effect was noticed in this study. 
However, severe hypotension requiring resuscitation 
treatments did not develop for increasing age, or ASA physi-
cal status groups. The influence of age on propofol dose in 
decreasing systolic blood pressure has already been described.12   
In addition, propofol-based sedation did not increase the 
complication rate.6,13
Low-dose of midazolam combined with low-dose   fentanyl 
and propofol did not prolong recovery time.   Consequently, 
sick patients (ASA physical status III–IV) may be sedated 
utilizing this combination technique. However, the combined 
group studied was small, and more patients are therefore 
needed.
The present study used only standard monitoring, including 
an assessment of blood pressure, pulse rate, respiratory rate 
and pulse oximetry, as well as electrocardiogram. We detected 
a relatively high overall rate of adverse events in both groups. 
This rate is higher than that commonly reported, and there 
may be several explanations. We used these criteria in defining 
adverse events: hypo/hypertension and brady/tachycardia 
measured as the changes of blood pressure and heart rate of 
more than 20% of baseline values. Hypoxia was defined as 
SpO2 , 90%. Hypercapnia (ETCO2 . 50 mm Hg) could not 
be detected directly in this study. Moreover, if only serious 
adverse events are included, the adverse event rate is only 1.8% 
in the nonsick group and 2.0% in the sick group, which cor-
responds to previously published studies.14 Moreover, if only 
serious adverse events are included, the adverse event rate is 
only 1.8% in the nonsick group and 2.0% in the sick group.
In one cohort study, 1000 patients undergoing endoscopic 
ultrasonography procedure were sedated with propofol for 
deep sedation and received meperidine and midazolam for 
moderate sedation. There did not appear to be a significant 
difference between complication rates for deep sedation and for 
moderate sedation. There were no serious adverse events.15 We 
believe that the appropriate selection of patients for sedation 
is very important for everyday practice and will most likely 
reduce the rate of adverse events. Finally, the use of pulse oxi-
metry to monitor hypoxemia is important, especially in cases 
when supplemental oxygen is administered. At our institution, 
most procedures are performed in the prone position. The pres-
ent study demonstrates that ERCP can be effectively performed 
in this position with the patients under deep sedation.
Data from our previous study showed that both patient and 
endoscopist satisfaction in sedated patients was higher than 
in nonsedated patients. The use of sedation was the major 
determinant of patient satisfaction and willingness to repeat.16 
However, deep sedation contributed to an increased recovery 
room time. Among all of these benefits, it is advantageous to 
identify the particular factors that might encourage patients 
to undergo ERCP procedure with deep sedation. Moreover, 
the present study showed that ERCP procedure in sick 
elderly patients can be performed safely and effectively with Therapeutics and Clinical Risk Management
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a lower complication rate under PBDS technique. We think 
that low-dose fentanyl combined with low-dose midazolam 
and low-dose propofol is the ideal combination for PBDS. In 
our hospital, intravenous sedation is extensively used for GI 
endoscopy procedures in geriatric patients.17 However, this is 
not widespread in the district community hospital.
This study has a few limitations. First, there is the wide 
range in age of the patients in our study. Drug requirements, 
recovery time, and side effects can be related to patient’s age. 
Second, inaccurate and incomplete documentation of certain 
measures, as occurs with many chart reviews, also occurred 
in this study. Third, the limitation of monitoring, such as of 
ETCO2, could result in a lower rate of adverse events. Finally, 
different anesthesiologists define complications differently. 
Overall, despite these limitations, we are, however, confi-
dent that these findings are generalizable to the practice of 
ERCP procedure using deep sedation. Finally, because the 
rate of serious complications in our series was low, further 
studies in larger prospective groups of patients are therefore   
needed.
Conclusion
We report the performance of the clinical efficacy of PBDS 
regimen utilizing anesthetic personnel with appropriate basic 
monitoring for ERCP procedure in sick, elderly patients in a 
unit outside the OR from a tertiary-care teaching hospital in a 
developing country. The findings of the present study showed 
that the ERCP procedure done by PBDS technique for sick, 
elderly patients was safe and effective, and its efficacy was 
not different or worse than in nonsick elderly patients. The 
combination of low-dose fentanyl, midazolam, and propofol 
may be beneficial.
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